<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T02:49:22Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:9628651" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:9628651</identifier>
        <datestamp>2022-11-03</datestamp>
        <setSpec>bmjo</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">BMJ Open</journal-id>
              <journal-id journal-id-type="iso-abbrev">BMJ Open</journal-id>
              <journal-id journal-id-type="hwp">bmjopen</journal-id>
              <journal-id journal-id-type="publisher-id">bmjopen</journal-id>
              <journal-title-group>
                <journal-title>BMJ Open</journal-title>
              </journal-title-group>
              <issn pub-type="epub">2044-6055</issn>
              <publisher>
                <publisher-name>BMJ Publishing Group</publisher-name>
                <publisher-loc>BMA House, Tavistock Square, London, WC1H 9JR</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC9628651</article-id>
              <article-id pub-id-type="pmcid">PMC9628651</article-id>
              <article-id pub-id-type="pmc-uid">9628651</article-id>
              <article-id pub-id-type="pmid">36316073</article-id>
              <article-id pub-id-type="pmid">36316073</article-id>
              <article-id pub-id-type="publisher-id">bmjopen-2022-062134</article-id>
              <article-id pub-id-type="doi">10.1136/bmjopen-2022-062134</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Epidemiology</subject>
                </subj-group>
                <subj-group subj-group-type="hwp-journal-coll">
                  <subject>1506</subject>
                  <subject>1692</subject>
                </subj-group>
                <series-title>Protocol</series-title>
              </article-categories>
              <title-group>
                <article-title>Data-informed stepped care to improve youth engagement in HIV care in Kenya: a protocol for a cluster randomised trial of a health service intervention</article-title>
              </title-group>
              <contrib-group>
                <contrib id="author-56319776" contrib-type="author" corresp="yes">
                  <name>
                    <surname>Kohler</surname>
                    <given-names>Pamela</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">1</xref>
                  <xref rid="aff2" ref-type="aff">2</xref>
                </contrib>
                <contrib id="author-73137387" contrib-type="author">
                  <name>
                    <surname>Agot</surname>
                    <given-names>Kawango</given-names>
                  </name>
                  <xref rid="aff3" ref-type="aff">3</xref>
                </contrib>
                <contrib id="author-62716189" contrib-type="author">
                  <name>
                    <surname>Njuguna</surname>
                    <given-names>Irene N</given-names>
                  </name>
                  <xref rid="aff2" ref-type="aff">2</xref>
                  <xref rid="aff4" ref-type="aff">4</xref>
                </contrib>
                <contrib id="author-95866169" contrib-type="author">
                  <name>
                    <surname>Dyer</surname>
                    <given-names>Jessica</given-names>
                  </name>
                  <xref rid="aff2" ref-type="aff">2</xref>
                </contrib>
                <contrib id="author-95866191" contrib-type="author">
                  <name>
                    <surname>Badia</surname>
                    <given-names>Jacinta</given-names>
                  </name>
                  <xref rid="aff3" ref-type="aff">3</xref>
                </contrib>
                <contrib id="author-95865384" contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-0579-9443</contrib-id>
                  <name>
                    <surname>Jiang</surname>
                    <given-names>Wenwen</given-names>
                  </name>
                  <xref rid="aff5" ref-type="aff">5</xref>
                </contrib>
                <contrib id="author-63085761" contrib-type="author">
                  <name>
                    <surname>Beima-Sofie</surname>
                    <given-names>Kristin</given-names>
                  </name>
                  <xref rid="aff2" ref-type="aff">2</xref>
                </contrib>
                <contrib id="author-95866241" contrib-type="author">
                  <name>
                    <surname>Chhun</surname>
                    <given-names>Nok</given-names>
                  </name>
                  <xref rid="aff2" ref-type="aff">2</xref>
                </contrib>
                <contrib id="author-95866308" contrib-type="author">
                  <name>
                    <surname>Inwani</surname>
                    <given-names>Irene</given-names>
                  </name>
                  <xref rid="aff6" ref-type="aff">6</xref>
                </contrib>
                <contrib id="author-95865398" contrib-type="author">
                  <name>
                    <surname>Shah</surname>
                    <given-names>Seema K</given-names>
                  </name>
                  <xref rid="aff7" ref-type="aff">7</xref>
                  <xref rid="aff8" ref-type="aff">8</xref>
                </contrib>
                <contrib id="author-54958049" contrib-type="author">
                  <name>
                    <surname>Richardson</surname>
                    <given-names>Barbra A</given-names>
                  </name>
                  <xref rid="aff9" ref-type="aff">9</xref>
                  <xref rid="aff10" ref-type="aff">10</xref>
                </contrib>
                <contrib id="author-95865401" contrib-type="author">
                  <name>
                    <surname>Chaktoura</surname>
                    <given-names>Nahida</given-names>
                  </name>
                  <xref rid="aff11" ref-type="aff">11</xref>
                </contrib>
                <contrib id="author-55532117" contrib-type="author">
                  <name>
                    <surname>John-Stewart</surname>
                    <given-names>Grace</given-names>
                  </name>
                  <xref rid="aff12" ref-type="aff">12</xref>
                </contrib>
              </contrib-group>
              <aff id="aff1"><label>1</label><institution content-type="department">Child, Family, and Population Health Nursing</institution>, <institution>University of Washington</institution>, <addr-line content-type="city">Seattle</addr-line>, <addr-line content-type="state">Washington</addr-line>, <country>USA</country></aff>
              <aff id="aff2"><label>2</label><institution content-type="department">Global Health</institution>, <institution>University of Washington</institution>, <addr-line content-type="city">Seattle</addr-line>, <addr-line content-type="state">Washington</addr-line>, <country>USA</country></aff>
              <aff id="aff3"><label>3</label><institution>Impact Research and Development Organisation</institution>, <addr-line content-type="city">Kisumu</addr-line>, <country>Kenya</country></aff>
              <aff id="aff4"><label>4</label><institution content-type="department">Research &amp; Programs</institution>, <institution>Kenyatta National Hospital</institution>, <addr-line content-type="city">Nairobi</addr-line>, <country>Kenya</country></aff>
              <aff id="aff5"><label>5</label><institution content-type="department">Epidemiology</institution>, <institution>University of Washington</institution>, <addr-line content-type="city">Seattle</addr-line>, <addr-line content-type="state">Washington</addr-line>, <country>USA</country></aff>
              <aff id="aff6"><label>6</label><institution content-type="department">Pediatrics</institution>, <institution>Kenyatta National Hospital</institution>, <addr-line content-type="city">Nairobi</addr-line>, <country>Kenya</country></aff>
              <aff id="aff7"><label>7</label><institution content-type="department">Pediatrics</institution>, <institution>Northwestern University Feinberg School of Medicine</institution>, <addr-line content-type="city">Chicago</addr-line>, <addr-line content-type="state">Illinois</addr-line>, <country>USA</country></aff>
              <aff id="aff8"><label>8</label><institution>Ann and Robert H Lurie Children's Hospital of Chicago</institution>, <addr-line content-type="city">Chicago</addr-line>, <addr-line content-type="state">Illinois</addr-line>, <country>USA</country></aff>
              <aff id="aff9"><label>9</label><institution content-type="department">Global Health, Biostatistics</institution>, <institution>University of Washington</institution>, <addr-line content-type="city">Seattle</addr-line>, <addr-line content-type="state">Washington</addr-line>, <country>USA</country></aff>
              <aff id="aff10"><label>10</label><institution content-type="department">Vaccine and Infectious Disease Division</institution>, <institution>Fred Hutchinson Cancer Research Center</institution>, <addr-line content-type="city">Seattle</addr-line>, <addr-line content-type="state">Washington</addr-line>, <country>USA</country></aff>
              <aff id="aff11"><label>11</label><institution content-type="department">Eunice Kennedy Shriver National Institute of Child Health and Human Development</institution>, <institution>National Institutes of Health</institution>, <addr-line content-type="city">Washington</addr-line>, <addr-line content-type="state">District of Columbia</addr-line>, <country>USA</country></aff>
              <aff id="aff12"><label>12</label><institution content-type="department">Global Health, Epidemiology, Pediatrics, Medicine</institution>, <institution>University of Washington</institution>, <addr-line content-type="city">Seattle</addr-line>, <addr-line content-type="state">Washington</addr-line>, <country>USA</country></aff>
              <author-notes>
                <corresp><label>Correspondence to</label> Dr Pamela Kohler; <email>pkohler2@uw.edu</email></corresp>
              </author-notes>
              <pub-date pub-type="collection">
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="epub">
                <day>31</day>
                <month>10</month>
                <year>2022</year>
              </pub-date>
              <volume>12</volume>
              <issue>10</issue>
              <elocation-id>e062134</elocation-id>
              <history>
                <date date-type="received">
                  <day>23</day>
                  <month>2</month>
                  <year>2022</year>
                </date>
                <date date-type="accepted">
                  <day>10</day>
                  <month>10</month>
                  <year>2022</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</copyright-statement>
                <copyright-year>2022</copyright-year>
                <ali:free_to_read/>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbynclicense" start_date="2022-10-31">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref>
                  <license-p>This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>.</license-p>
                </license>
              </permissions>
              <self-uri xlink:title="pdf" xlink:href="bmjopen-2022-062134.pdf"/>
              <self-uri content-type="reviewers-comments-pdf" xlink:href="bmjopen-2022-062134.reviewer_comments.pdf"/>
              <self-uri content-type="draft-revisions-pdf" xlink:href="bmjopen-2022-062134.draft_revisions.pdf"/>
              <abstract>
                <sec>
                  <title>Introduction</title>
                  <p>Adolescents and youth living with HIV (AYLHIV) have lower retention in care, adherence to treatment, and viral suppression compared with adults. Stepped care is a process by which clients are assigned to increasingly intensive services or ‘steps’ according to level of need. Differentiated care, in which stable clients access less frequent services, can be combined with stepped care to align needs and preferences of youth to promote optimal engagement in care.</p>
                </sec>
                <sec>
                  <title>Methods and analysis</title>
                  <p>This hybrid type I effectiveness implementation cluster randomised trial aims to evaluate a data-informed stepped care (DiSC) intervention for AYLHIV. AYLHIV ages 10–24 receiving care at 24 HIV treatment facilities in Kisumu, Homabay and Migori counties in Kenya will be enrolled. Twelve facilities will be randomised to the DiSC intervention, and 12 will provide standard care. A clinical assignment tool developed by the study team will be used at intervention sites to assign AYLHIV to one of four steps based on risk for loss to follow-up: differentiated care, standard care, counselling services or intensive support services. The primary clinical outcome is retention in care, specifically missed visits (failure to return within 30 days for any visit) and 12-month loss to follow-up. Implementation outcomes are based on the Reach, Effectiveness, Adoption, Implementation and Maintenance framework. Proportions of missed visits will be compared using mixed effect models clustered by facility and participant.</p>
                </sec>
                <sec>
                  <title>Ethics and dissemination</title>
                  <p>This study has been approved by the University of Washington Institutional Review Board (STUDY00011096), Maseno University Ethical Review Committee (MUERC/00917/20) and the Kenya National Commission for Science, Technology and Innovation (444824). AYLHIV provide written informed consent when legally permitted, or assent with caregiver permission for minors. Study staff will work with a Community Advisory Board, including youth members, to disseminate results via discussions, presentations, journal publications and local or international conferences.</p>
                </sec>
                <sec>
                  <title>Trial registration number</title>
                  <p><ext-link xlink:href="NCT05007717" ext-link-type="uri">NCT05007717</ext-link>.</p>
                </sec>
              </abstract>
              <kwd-group>
                <kwd>HIV &amp; AIDS</kwd>
                <kwd>Community child health</kwd>
                <kwd>Quality in health care</kwd>
                <kwd>Paediatric intensive &amp; critical care</kwd>
                <kwd>Clinical trials</kwd>
              </kwd-group>
              <funding-group specific-use="FundRef">
                <award-group id="funding-1">
                  <funding-source>
                    <institution-wrap>
                      <institution>Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>HD096906</award-id>
                  <award-id>PATC3H</award-id>
                  <award-id>UG3/UH3</award-id>
                </award-group>
              </funding-group>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>special-feature</meta-name>
                  <meta-value>unlocked</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <boxed-text id="BX1" position="float">
              <caption>
                <title>Strengths and limitations of this study</title>
              </caption>
              <list list-type="bullet">
                <list-item>
                  <p>Use of a data-driven approach to match adolescents and youth living with HIV to services according to need.</p>
                </list-item>
                <list-item>
                  <p>Includes implementation outcomes to account for context that will optimise both intervention approach and sustainability.</p>
                </list-item>
                <list-item>
                  <p>Integrates validated survey scales with routinely collected electronic medical records data to assess outcomes.</p>
                </list-item>
                <list-item>
                  <p>Overlap between standard of care and the intervention steps may limit ability to detect a significant difference in outcomes.</p>
                </list-item>
                <list-item>
                  <p>May be subject to routine care interruptions such as strikes, stock outs, the COVID-19 pandemic and workforce turnover that could undermine the intervention.</p>
                </list-item>
              </list>
            </boxed-text>
            <sec sec-type="intro" id="s1">
              <title>Introduction</title>
              <p>An estimated 88% of youth, including adolescents and youth living with HIV (AYLHIV) reside in sub-Saharan Africa.<xref rid="R1" ref-type="bibr">1</xref> Worldwide, 410 000 youth between the ages of 10 and 24 were newly infected with HIV in 2020, and perinatally infected children of the last decade are ageing into adolescence.<xref rid="R1" ref-type="bibr">1</xref> Compared with adults, youth have lower retention in care, adherence to antiretroviral therapy (ART) and viral suppression,<xref rid="R2" ref-type="bibr">2–8</xref> increasing the risk of HIV transmission and disease progression.<xref rid="R9" ref-type="bibr">9 10</xref> AYLHIV frequently fail to achieve viral suppression<xref rid="R11" ref-type="bibr">11 12</xref> with approximately 30% experiencing non-suppression or failure after 12 months on ART.<xref rid="R13" ref-type="bibr">13–17</xref></p>
              <p>Test and Start models, where individuals living with HIV are rapidly initiated on treatment, address loss to follow-up in the pre-ART period, with early evidence of success.<xref rid="R18" ref-type="bibr">18</xref> However, there are fears that increasing caseloads, interlinked burdens of disease, sudden epidemic outbreaks and other emerging health challenges will add to healthcare worker (HCW) burdens in already strained healthcare systems.<xref rid="R1" ref-type="bibr">1</xref> Differentiated models of service delivery have been proposed as a client-centred approach that simplifies and adapts HIV services across the cascade to better serve those in care and reduce unnecessary burdens on the health system.<xref rid="R19" ref-type="bibr">19</xref> However, due to poor retention outcomes, Kenyan guidelines classify all adolescents as ‘unstable’.<xref rid="R20" ref-type="bibr">20</xref> Thus, AYLHIV are currently not able to access differentiated approaches, including community-based refills or longer refill durations, which may benefit this population and free up HCW time to provide more intensive care to youth in need.</p>
              <p>Stepped care models, a process by which clients are assigned to intervention steps according to level of need, have been used in mental health fields to organise provision of services; and to support clients, HCWs and caregivers to identify the most effective interventions.<xref rid="R21" ref-type="bibr">21</xref> Models typically start with a low-intensity, evidence-based treatment and systematically progress to higher levels of care or intervention as clients fail to respond.<xref rid="R22" ref-type="bibr">22</xref> Early studies suggest that stepped care approaches improve access to care, client outcomes and programme efficiencies, including client volume.<xref rid="R23" ref-type="bibr">23–25</xref> A key feature of stepped care is outcome monitoring, giving both clients and HCWs feedback to inform care options and service delivery.</p>
              <p>One challenge with retention interventions is the ability to identify clients who need more intensive services before they are lost to follow-up. Clinical prediction tools classifying individuals into high and low-risk groups have potential to identify those in need of intervention and support more efficient service delivery prior to poor outcomes occuring.<xref rid="R26" ref-type="bibr">26–29</xref> Studies using these tools among key populations in the USA<xref rid="R26" ref-type="bibr">26 29</xref> and studies in Kenya<xref rid="R28" ref-type="bibr">28 30</xref> found clinical characteristics that were predictive of HIV acquisition. Similarly, tools using a minimal number of variables have been shown to predict virologic failure or mortality in adult cohorts in both the USA<xref rid="R31" ref-type="bibr">31</xref> and low resource settings.<xref rid="R31" ref-type="bibr">31–33</xref> A prediction tool for loss to follow-up could support HCWs to better identify youth at risk for missed visits, rather than waiting until loss occurs, and be used to assign youth into appropriate steps of service delivery. This study aims to evaluate a data-driven, stepped care intervention assigning AYLHIV in Kenya to differentiated or more intensive service steps.</p>
            </sec>
            <sec sec-type="methods" id="s2">
              <title>Methods and analysis</title>
              <sec id="s2-1">
                <title>Study design</title>
                <p>This hybrid type I effectiveness implementation parallel cluster randomised trial aims to evaluate the effectiveness and implementation of a data-informed stepped care (DiSC) intervention for AYLHIV in Kenya. We hypothesise that the DiSC intervention will result in better retention in care and viral suppression among AYLHIV in intervention sites compared with those in control sites. We hypothesise that the DiSC intervention will be integrated into routine AYLHIV service in a way that is feasible and acceptable for HCWs, reaches a high proportion of youth attending facilities and is able to be implemented with fidelity. Focus group discussions and in-depth interviews will support qualitative understanding and optimisation of study implementation.</p>
              </sec>
              <sec id="s2-2">
                <title>Study sites and population</title>
                <p>We will conduct this study at 24 HIV care facilities located in Kisumu, Homabay and Migori counties in Kenya. Eligible facilities include those with ≥100 AYLHIV enrolled in care, a functioning electronic medical records (EMR) system and interest in participating. Eligible AYLHIV are ages 10–24 and enrolled in HIV treatment at participating clinics. AYLHIV who are not aware of their HIV diagnosis will be excluded. We aim to enrol a minimum of 50 AYLHIV per site, up to a maximum of 6000 AYLHIV total.</p>
              </sec>
              <sec id="s2-3">
                <title>Patient and public involvement</title>
                <p>Grounded in the concept of the stepped care model used in mental health, the DiSC intervention was developed through a combination of: (1) review of stepped care practices in the USA, (2) preliminary data from a longitudinal cohort of &gt;1300 AYLHIV in Kenya and (3) a modified user-centred design (UCD) workshop with key stakeholders (AYLHIV, youth leaders, national and county health officials, HCWs and caregivers of AYLHIV). Cohort data were used to characterise the AYLHIV population and develop a clinical prediction tool for loss to follow-up to aide providers in assigning AYLHIV to care steps. These data, alongside information on stepped care, differentiated care policies, best practices for adolescent care, national guidelines and existing services in clinics in the catchment area, were presented to stakeholders at the UCD workshop. Given COVID-19 social gathering restrictions, the workshop included a series of small group meetings followed by a large group meeting, where participants discussed which services would be appropriate for each step, aligning current practices in facilities. Participants were encouraged to develop the most inclusive and simplest service allocation approach that would work in the largest number of facilities in Kenya. Following the workshops, the study team refined the clinical prediction tool and intervention steps based on the feedback of stakeholders.</p>
              </sec>
              <sec id="s2-4">
                <title>Conceptual framework</title>
                <p>This study uses a socio-ecological framework to understand adolescent care-seeking behaviours and is broadly informed by Andersen’s model of health service use<xref rid="R34" ref-type="bibr">34</xref> and elements of Pantin’s eco-developmental theory.<xref rid="R35" ref-type="bibr">35</xref> Andersen’s model describes how environmental factors, including the health system, interact with population factors to motivate individual uptake of health services. The developmental perspective in Pantin’s theory further suggests that these factors and relationships change during transition to adulthood. From a theoretical perspective, the stepped care model is grounded in Stages of Change Theory, tailoring different levels of care intensity to different stages of health behaviour change.<xref rid="R36" ref-type="bibr">36</xref></p>
              </sec>
              <sec id="s2-5">
                <title>Intervention components</title>
                <p>The DiSC intervention uses a clinical assessment tool, based on the original prediction tool, to assign AYLHIV to different levels—or steps—of care based on their health and psychosocial needs. As those with lower needs becomes eligible for less frequent contact, this allows more HCW time to concentrate on providing more intensive services (<xref rid="F1" ref-type="fig">figure 1</xref>). In addition to reinforcing standard of care elements, the intervention also includes HCW training of cognitive behavioural therapy (CBT) and motivational interviewing. These core components address social (transportation, school, social support); individual and family (stigma, depression, self-efficacy and motivation); and health system factors (service availability, quality of care, care coordination) as a holistic approach to promote retention, adherence and ultimately viral suppression.</p>
                <fig position="float" id="F1">
                  <label>Figure 1</label>
                  <caption>
                    <p>Model of the intervention. CBT, cognitive behavioural therapy; DiSC, data-informed stepped care.</p>
                  </caption>
                  <graphic xlink:href="bmjopen-2022-062134f01" position="float"/>
                </fig>
              </sec>
              <sec id="s2-6">
                <title>Intervention procedures</title>
                <p>At enrolment and at every visit, HCWs will use the assessment tool to determine risk level and assign AYLHIV to a care step. Information will be obtained through self-report and HCW review of the medical record. The tool uses a combination of key loss to follow-up predictors and Kenyan national guidelines to match AYLHIV to one of four steps: differentiated care, standard of care, individual counselling or intensive support (<xref rid="T1" ref-type="table">table 1</xref>).</p>
                <table-wrap position="float" id="T1">
                  <label>Table 1</label>
                  <caption>
                    <p>Intervention steps</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <thead>
                      <tr>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">Step</td>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">Criteria for step assignment</td>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">Intervention steps</td>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">1</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">On ART for 12 months—AND—<break/>No opportunistic infection (OI) in last 6 months—AND—<break/>Viral suppression at last measure</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">
                          <bold>Differentiated care</bold>
                          <list list-type="bullet">
                            <list-item>
                              <p>Longer visit intervals</p>
                            </list-item>
                            <list-item>
                              <p>Pharmacy fast track</p>
                            </list-item>
                          </list>
                        </td>
                      </tr>
                      <tr>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">2</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Does not meet step 1 criteria (above)—OR—<break/>Patient preference for standard care—OR—<break/>Pregnant/breastfeeding</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">
                          <bold>Standard care</bold>
                          <list list-type="bullet">
                            <list-item>
                              <p>Job tools for OIs, pregnancy, newly enrolled</p>
                            </list-item>
                            <list-item>
                              <p>Support groups</p>
                            </list-item>
                            <list-item>
                              <p>Standard visit intervals</p>
                            </list-item>
                          </list>
                        </td>
                      </tr>
                      <tr>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">3</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">PHQ-2 score indicating depression—OR—<break/>Missed one or more visits in last 6 months</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">
                          <bold>Individual counselling</bold>
                          <list list-type="bullet">
                            <list-item>
                              <p>Motivational interviewing</p>
                            </list-item>
                            <list-item>
                              <p>Cognitive behavioural therapy sessions</p>
                            </list-item>
                          </list>
                        </td>
                      </tr>
                      <tr>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">4</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Unsuppressed viral load (VL)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">
                          <bold>Intensive support services</bold>
                          <list list-type="bullet">
                            <list-item>
                              <p>Adherence counselling</p>
                            </list-item>
                            <list-item>
                              <p>Facilitated case conference across sites</p>
                            </list-item>
                            <list-item>
                              <p>Transportation support or home visits</p>
                            </list-item>
                          </list>
                        </td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="T1_FN1">
                      <p>ART, antiretroviral therapy; PHQ-2, Patient Health Questionnaire-2.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <p>At the lowest step, AYLHIV who adhere well to treatment with no missed visits or health concerns will be assigned to receive differentiated care services, including multi-month refills, longer visit intervals and/or fast-track visits. AYLHIV with health concerns (pregnancy, opportunistic infections or TB) or those newly enrolled in care will be assigned to the second step, receiving standard care under Ministry of Health guidelines. AYLHIV with a history of missed visits in the past 6 months or depressive symptoms on standardised Patient Health Questionnaire-2 (PHQ-2) depression screening will be assigned to the third step, individual counselling. Within that step, those with a history of missed visits will receive one motivational interviewing session, and those with depressive symptoms will receive four CBT counselling sessions and referral to further mental health evaluation and treatment where warranted. The last step, intensive support, includes AYLHIV with unsuppressed viral load (VL). They receive services from steps 2 and 3 as needed, and enhanced adherence counselling with case management services such as home visits or transportation support as needed. The study team will guide facility-based quality improvement at intervention sites to monitor unsuppressed clients and support timely return of VL results. Control sites will continue with standard care for AYLHIV clinic visits according to national guidelines.</p>
              </sec>
              <sec id="s2-7">
                <title>Recruitment and retention procedures</title>
                <p>The sampling frame includes 55 clinics in three high-burden counties in Western Kenya. Among those, 24 clinics that meet eligibility criteria have the highest youth enrolment, and whose leadership is willing to participate will be selected and randomised to intervention or control. AYLHIV in participating facilities who are aware of their HIV status will be identified by facility providers and referred to the study team for eligibility screening and consent. A standard recruitment script with talking points will be used. Recruitment will be conducted during different days and times of the week, during at least two school breaks and ‘youth friendly days’ to maximise enrolment. AYLHIV at intervention sites will be consented for participation in the DiSC intervention and longitudinal surveys. Control sites will be consented for longitudinal surveys only. AYLHIV participants will have 12 months of follow-up time.</p>
              </sec>
              <sec id="s2-8">
                <title>Randomisation and blinding</title>
                <p>A total of 24 clinics will be randomised in a 1:1 ratio using computer generated random numbers to either intervention or control, using restricted randomisation to balance county representation and facility volume, aiming to balance these variables between arms. Randomisation will be done prior to study initiation at the University of Washington by a biostatistician not involved in study procedures. A list of clinics with their allocation arms will be sent to the study team. The intervention is administered at the clinic level; thus, it is not possible to blind participating clinics or study team members.</p>
              </sec>
              <sec id="s2-9">
                <title>Outcome measures</title>
                <p>The primary outcome is retention in care, measured as both the proportion of missed visits 1 year after enrolment, and the proportion of AYLHIV who became lost to follow-up with no subsequent return to care during the study period (<xref rid="T2" ref-type="table">table 2</xref>). Secondary outcomes are viral non-suppression, defined as HIV VL &gt;1000 copies/mL; receipt of differentiated services (multimonth refills or fast-track visits); and ART adherence defined as a remaining pill count&lt;80% (estimated by days used and inter-visit interval).</p>
                <table-wrap position="float" id="T2">
                  <label>Table 2</label>
                  <caption>
                    <p>Study outcomes and data sources</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <thead>
                      <tr>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">Outcome</td>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">Definition</td>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">Source</td>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">Timing</td>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" valign="top" colspan="4" rowspan="1">Primary outcome—retention in care</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Missed visit</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Not seen within 30 days of a scheduled visit</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">EMR data</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">All visits occurring during the 12 months period after the study enrolment visit</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Loss to follow-up</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Not seen within 30 days of a scheduled visit and does not return to care within the 12 month study interval</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">EMR data</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">All visits after the first study visit until event or end of 12 months follow-up. Participants marked as ‘transferred out’ or ‘died’ will be censored</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" colspan="4" rowspan="1">Secondary outcomes</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Viral non-suppression</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">HIV VL &gt;1000 copies/mL</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">National data</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">All visits from enrolment to 12 months follow-up</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Receiving differentiated care</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Assigned to long inter-visit intervals or fast-track visits</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">EMR data</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">All visits from enrolment to 12 months follow-up</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Adherence</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Pill coverage estimated by days of dosing and inter-visit interval since last visit &gt;80%</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">EMR data</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">All visits from enrolment to 12 months follow-up</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="T2_FN1">
                      <p>EMR, electronic medical records; VL, viral load.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <p>Implementation assessment includes barriers, facilitators, and adaptation strategies of intervention implementation. Outcome measures use the Reach, Effectiveness, Adoption, Implementation and Maintenance framework.<xref rid="R37" ref-type="bibr">37</xref> We will routinely evaluate the proportion of youth enrolled in the intervention (Reach), the proportion of trained HCWs using the intervention (Adoption), proportion of youth assigned to correct step (Fidelity), proportion of youth exposed to correct services in each step (Fidelity), types of HCW adaptations made for optimising delivery (Implementation) and the proportion of facilities using the intervention tools at study end (Maintenance) using study-specific case report forms (<xref rid="T3" ref-type="table">table 3</xref>). We will also evaluate HCW perceptions of acceptability, feasibility and appropriateness of the DiSC intervention.<xref rid="R38" ref-type="bibr">38 39</xref></p>
                <table-wrap position="float" id="T3">
                  <label>Table 3</label>
                  <caption>
                    <p>Implementation outcomes</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <thead>
                      <tr>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">Outcome</td>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">Definition</td>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">Timing</td>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Reach</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Proportion of youth who are exposed to the intervention among all youth attending clinic</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Daily</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Adoption</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Proportion of trained providers who are using the DiSC intervention with youth</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Bi-monthly for 6 months and post-trial</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Implementation</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Characterisation of adaptations and strategies used to optimise early implementation</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Bi-monthly for 6 months and post-trial</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Maintenance</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Proportion of facilities delivering the DiSC intervention with rates of adoption and fidelity at study end; characterisation of barriers and facilitators to sustainability</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Post-trial</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Fidelity</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Proportion of youth who are correctly assigned to each step; proportion of youth who correctly receive services aligned to assigned step</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Bi-monthly for 6 months and post-trial</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Acceptability</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Perception among implementation stakeholders and patients that the DiSC intervention is agreeable, palatable or satisfactory</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Baseline, bi-monthly for 6 months and post-trial</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Feasibility</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Perception of the extent to which the DiSC intervention can be successfully used or carried out within a given setting</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Baseline, bi-monthly for 6 months and post-trial</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Appropriateness</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Perception of the perceived fit, relevance, or compatibility of the DiSC intervention for the specific setting, and whether it addresses the issue of loss to follow-up among AYLHIV</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Baseline, bi-monthly for 6 months and post-trial</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="T3_FN1">
                      <p>AYLHIV, adolescents and youth living with HIV; DiSC, data-informed stepped care.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec id="s2-10">
                <title>Data collection</title>
                <p>We will abstract AYLHIV medical record data at baseline, and every 6 months. Data from all enrolled AYLHIV with at least one clinic record within the 12 month period prior to the first data abstraction date will be included. Data will be abstracted at the facility or at the office of the technical partner that supports the EMR system at the facility. The EMR system captures data on client anthropometric measures, demographics, HIV testing history, clinical history, ART adherence data, laboratory data, CD4 count, transfers and discontinuations. If EMR data are unavailable, paper records will be abstracted using mobile REDCap, which enables automatic upload of data to a secure, password-protected study server. Routine HIV VL testing (done 6 months after ART initiation, then annually) will be abstracted from the Kenya National AIDS &amp; STI Control Program database.</p>
                <p>Youth surveys will be administered by study staff following intervention assignment by the HCW. Surveys include questions on sociodemographic,<xref rid="R40" ref-type="bibr">40</xref> healthcare use, stigma,<xref rid="R41" ref-type="bibr">41</xref> sexual behaviour and violence using questions adapted from the WHO Multi Country Study,<xref rid="R42" ref-type="bibr">42</xref> social support by the Multidimensional Scale of Perceived Social Support,<xref rid="R43" ref-type="bibr">43</xref> depressive symptoms by PHQ-9),<xref rid="R44" ref-type="bibr">44</xref> anxiety by General Anxiety Disorder-7,<xref rid="R45" ref-type="bibr">45</xref> resilience by Connor-Davidson Resilience Scale-2,<xref rid="R46" ref-type="bibr">46</xref> self-efficacy,<xref rid="R47" ref-type="bibr">47</xref> personal health knowledge, HIV disclosure, and medication adherence by HIV Treatment Adherence Self-Efficacy Scale.<xref rid="R48" ref-type="bibr">48</xref> Surveys will be administered every 6 months either in-person or over phone by a trained study staff. Survey visits will coincide with clinic visits whenever possible. At the end of the study, additional surveys will be given to a random sample of youth and caregivers in intervention sites to evaluate satisfaction with care. We will also conduct in-depth interviews (IDIs) or focus group discussions (FGDs) with youth in intervention sites to determine acceptability, feasibility and satisfaction with the intervention.</p>
                <p>Facility managers will complete baseline and annual facility surveys to understand baseline resource capacity to implement future interventions and modifiable and non-modifiable health system factors. Variables will include availability of youth-friendly services, management and referral systems, and differentiated care services available. We will conduct pre-trial surveys with HCWs to assess structural readiness for implementation<xref rid="R39" ref-type="bibr">39</xref> and intervention beliefs about acceptability, feasibility and appropriateness of intervention implementation. During the first 6 months of the trial, HCWs will participate in twice-monthly continuous quality improvement (CQI) meetings using plan-do-study-act processes to assess specific adaptations that optimise reach, adoption, fidelity, acceptability and feasibility. Prior to each meeting, HCWs will complete surveys to evaluate changes in implementation. We will conduct FGDs with HCWs in intervention sites at 6 months post-intervention implementation, and FGDs, IDIs and surveys with HCWs post-trial to determine experiences with the DiSC intervention and evaluate barriers and facilitators of intervention utilisation. All FGDs and IDIs will be guided by the Consolidated Framework for Implementation Research.<xref rid="R49" ref-type="bibr">49 50</xref></p>
              </sec>
              <sec id="s2-11">
                <title>Sample size calculation</title>
                <p>We estimate that participating facilities will have an average of 100–200 AYLHIV in care per clinic. Based on preliminary data, we assume that 75% will remain in care by the end of the 12-month follow-up period. Assuming 12 facilities per arm, α=0.05, a two-sided test, and a coefficient of variation of 0.10, we have 80% power to detect a 14% difference (75%–89%) with ≥150 AYLHIV per facility, and a 15% difference (75%–90%) with ≥50 AYA per facility. Assuming a coefficient of variation of 0.15, we have 80% power to detect a 17% difference (75%–92%) with≥50 AYLHIV per facility.</p>
              </sec>
              <sec id="s2-12">
                <title>Statistical methods and analysis</title>
                <p>Characteristics of facilities randomised to each arm will be summarised using descriptive statistics. The proportion of missed visits will be compared between study arms using mixed effect models clustered by facility and participant. Time to loss to follow-up will be compared between arms using survival curves and Cox proportional hazards regression, with censoring of deaths or transfers. Proportions of secondary outcomes (viral non-suppression, differentiated care, adherence) will each be compared between study arms using mixed effect models clustered by facility and participant. Exploratory sub-group analyses for missed visits and loss to follow-up will be performed by gender, age-group and step assignment groups. Facility factors including concurrent adolescent-friendly services and high/low performance will be evaluated as moderators of intervention effectiveness. Pre-trial and post-trial survey data will be summarised to evaluate frequencies, variability and associations. Adaptations made to the intervention during the CQI process will be categorised using the Framework for Reporting Adaptations and Modifications Expanded,<xref rid="R51" ref-type="bibr">51</xref> and compared with variations in implementation outcomes to identify modifications associated with sustained improvements in implementation. Qualitative data will be analysed using a combination of thematic<xref rid="R52" ref-type="bibr">52</xref> and directed content analysis<xref rid="R53" ref-type="bibr">53</xref> approaches to characterise the determinants of implementation success and explore personal experiences with the DiSC intervention.</p>
              </sec>
            </sec>
            <sec id="s3">
              <title>Ethics and dissemination</title>
              <p>This study has been approved by the University of Washington Institutional Review Board (STUDY00011096) and Maseno University Ethical Review Committee (MUERC/00917/20). Protocol modifications will be submitted to both committees. Youth participants will provide written informed consent for study procedures as permitted by law; youth without capacity to consent will provide assent while their caregivers will give consent unless exempted by the two ethics bodies. A sample consent form is provided in the <xref rid="SP1" ref-type="supplementary-material">online supplemental appendix</xref>. The trial will be monitored by a Data Safety and Monitoring Board (DSMB), as well as by external monitors appointed by the funder. Severe adverse events will be monitored and reported to the DSMB and study monitors in real time. All data will be kept confidential and de-identified by the data manager. Consent documents will be kept separate from study data and secured in a locked cabinet.</p>
              <supplementary-material id="SP1" position="float" content-type="local-data">
                <object-id pub-id-type="doi">10.1136/bmjopen-2022-062134.supp1</object-id>
                <label>Supplementary data</label>
                <p>
                  <inline-supplementary-material id="SS1" xlink:href="bmjopen-2022-062134supp001.pdf" content-type="local-data"/>
                </p>
              </supplementary-material>
              <p>Study staff will work with a Community Advisory Board, including youth members, to disseminate results to participants and the community via discussions and presentations. We will further disseminate findings through journal publications and local or international conferences. Data will be submitted to the National Institute of Child Health and Human Development (NICHD) Data and Specimen Hub (DASH) no later than 1 year after acceptance of the primary manuscript or study closure, whichever comes first.</p>
              <p>The trial is registered at ClinicalTrials.gov, NCT05007717. Enrolment took place 19 April to 19 July 2022; the trial will conclude by 31 July 2023.</p>
            </sec>
            <sec sec-type="discussion" id="s4">
              <title>Discussion</title>
              <p>This study is part of the Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource Constrained Settings (PAT<sup>3</sup>CH) consortium, a NICHD-funded international group of combination individual, family, community, structural and health system intervention studies to improve health outcomes among adolescents and youth at risk for or living with HIV.<xref rid="R54" ref-type="bibr">54</xref> Our study aims to evaluate a stepped care intervention to tailor service delivery according to AYLHIV needs and ultimately improve retention in care and other clinical and psychosocial outcomes. The intervention has been developed based on a theoretical foundation and informed by pilot data and stakeholder input.</p>
              <p>Our multicomponent intervention is based on a combination of evidence-based interventions and recommended but untested strategies to clearly allocate services using a pre-specified algorithm/tool to tailor specific services for AYLHIV.<xref rid="R55" ref-type="bibr">55–59</xref> Services include individual motivational interviewing to preemptively improve retention, CBT to address depressive symptoms, and enhanced counselling for adherence. System improvements include facility quality improvement and guideline refreshers. Together, these intensive individual and system-level interventions as elements of higher steps address current gaps in care including resources for mental health treatment<xref rid="R60" ref-type="bibr">60</xref> and a breakdown in action on unsuppressed VL results.<xref rid="R61" ref-type="bibr">61</xref> One way our approach differs from US-based stepped care interventions is that we include risk for non-retention, rather than waiting for non-retention outcomes alone, to assign AYLHIV to steps.</p>
              <p>The use of a data-driven tool to identify AYLHIV at highest risk of loss to follow-up is consistent with stepped care principles of using routine data to inform care needs. The risk assessment provides a systematic way to identify AYLHIV who are most likely to be safe to initiate on differentiated services, despite being classified by Kenya’s MOH as a high-risk group overall. Currently, differentiated services like longer visit intervals are only applied to stable adults, due to concerns that AYLHIV may not be able to sustain adherence and retention without more frequent contact. Our approach will emulate adult standards for differentiated care in terms of identifying eligible AYLHIV. Data from this study will provide important evidence for Ministries of Health who seek to extend differentiated care to AYLHIV. Simultaneous measurement of implementation outcomes throughout the trial will help to determine best practices to ensure sustainability and inform issues of setting and context, which may contribute to eventual scale-up if the intervention is found effective.</p>
              <p>This trial has limitations. Elements of several care steps are offered in control settings, which may limit our ability to detect a difference between intervention and control arms, and there is a possibility of transfer of enrolled clients between facilities. The study is operating through routine care programmes in Kenya, which are subject to strikes, stock outs, the COVID-19 pandemic, and workforce turnover and may undermine fidelity of the intervention over the study course. Furthermore, the age range represents a heterogeneous group of AYLHIV, and our sample size may limit our ability to detect differences in effectiveness among key subgroups. Finally, there are social factors that influence AYLHIV uptake of services and may not be addressed within the health system alone.</p>
              <p>In summary, this a data-driven, provider-led, health system intervention aims to identify young people most at risk for loss to HIV care, sub-optimal adherence and viral failure. Our stepped care approach, combined with a clinical prediction tool, is a timely and flexible intervention in the context of differentiated care and numerous ongoing care initiatives. By improving engagement in care and optimising provision of limited resources, this intervention may ultimately improve health among adolescents and youth in Kenya and provide support for testing stepped care approaches in other settings.</p>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supplementary Material</title>
              <supplementary-material content-type="local-data" id="d64e314">
                <caption>
                  <title>Reviewer comments</title>
                </caption>
                <media xlink:href="bmjopen-2022-062134.reviewer_comments.pdf"/>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="d64e315">
                <caption>
                  <title>Author's
manuscript</title>
                </caption>
                <media xlink:href="bmjopen-2022-062134.draft_revisions.pdf"/>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <fn-group>
              <fn fn-type="other">
                <p><bold>Contributors:</bold> PK, GJ-S and KA are principal investigators. PK, GJ-S, KA, BAR and KB-S designed the study and supervised trial protocol development; IN, JD, WJ, SS, II, NC and JB contributed to the study protocol. BAR and WJ were responsible for statistical design; KB-S and NC were responsible for implementation science approaches. PK drafted the initial manuscript and all authors critically revised, read and approved the final manuscript.</p>
              </fn>
              <fn fn-type="other">
                <p><bold>Funding:</bold> This work was supported through the PATC3H consortium, funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health under grant UG3/UH3 HD096906.</p>
              </fn>
              <fn fn-type="COI-statement">
                <p><bold>Competing interests:</bold> None declared.</p>
              </fn>
              <fn fn-type="other">
                <p><bold>Patient and public involvement:</bold> Patients and/or the public were involved in the design, or conduct, or reporting, or dissemination plans of this research. Refer to the Methods section for further details.</p>
              </fn>
              <fn fn-type="other">
                <p><bold>Provenance and peer review:</bold> Not commissioned; externally peer reviewed.</p>
              </fn>
              <fn fn-type="other">
                <p><bold>Supplemental material:</bold> This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.</p>
              </fn>
            </fn-group>
            <sec sec-type="ethics-statement">
              <title>Ethics statements</title>
              <sec>
                <title>Patient consent for publication</title>
                <p content-type="ethics-consent-to-publish">Consent obtained directly from patient(s).</p>
              </sec>
            </sec>
            <ref-list>
              <title>References</title>
              <ref id="R1">
                <label>1</label>
                <mixed-citation publication-type="webpage"><person-group person-group-type="author"><collab>UNAIDS</collab></person-group>. <article-title>Seizing the moment: global AIDS update 2020</article-title>, <year>2020</year>. Available: <uri xlink:href="https://www.unaids.org/sites/default/files/media_asset/2020_global-aids-report_en.pdf">https://www.unaids.org/sites/default/files/media_asset/2020_global-aids-report_en.pdf</uri></mixed-citation>
              </ref>
              <ref id="R2">
                <label>2</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lamb</surname><given-names>MR</given-names></string-name>, <string-name><surname>Fayorsey</surname><given-names>R</given-names></string-name>, <string-name><surname>Nuwagaba-Biribonwoha</surname><given-names>H</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>High attrition before and after art initiation among youth (15-24 years of age) enrolled in HIV care</article-title>. <source>AIDS</source><year>2014</year>;<volume>28</volume>:<elocation-id>559-68</elocation-id>. <pub-id pub-id-type="doi">10.1097/QAD.0000000000000054</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/24076661?><pub-id pub-id-type="pmid">24076661</pub-id></mixed-citation>
              </ref>
              <ref id="R3">
                <label>3</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nachega</surname><given-names>JB</given-names></string-name>, <string-name><surname>Hislop</surname><given-names>M</given-names></string-name>, <string-name><surname>Nguyen</surname><given-names>H</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa</article-title>. <source>J Acquir Immune Defic Syndr</source><year>2009</year>;<volume>51</volume>:<elocation-id>65-71</elocation-id>. <pub-id pub-id-type="doi">10.1097/QAI.0b013e318199072e</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/19282780?><pub-id pub-id-type="pmid">19282780</pub-id></mixed-citation>
              </ref>
              <ref id="R4">
                <label>4</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Salou</surname><given-names>M</given-names></string-name>, <string-name><surname>Dagnra</surname><given-names>AY</given-names></string-name>, <string-name><surname>Butel</surname><given-names>C</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>High rates of virological failure and drug resistance in perinatally HIV-1-infected children and adolescents receiving lifelong antiretroviral therapy in routine clinics in Togo</article-title>. <source>J Int AIDS Soc</source><year>2016</year>;<volume>19</volume>:<elocation-id>20683</elocation-id>. <pub-id pub-id-type="doi">10.7448/IAS.19.1.20683</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/27125320?><pub-id pub-id-type="pmid">27125320</pub-id></mixed-citation>
              </ref>
              <ref id="R5">
                <label>5</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Judd</surname><given-names>A</given-names></string-name>, <string-name><surname>Collins</surname><given-names>IJ</given-names></string-name>, <string-name><surname>Parrott</surname><given-names>F</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Growing up with perinatal HIV: changes in clinical outcomes before and after transfer to adult care in the UK</article-title>. <source>J Int AIDS Soc</source><year>2017</year>;<volume>20</volume>:<elocation-id>21577</elocation-id>. <pub-id pub-id-type="doi">10.7448/IAS.20.4.21577</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/28530042?><pub-id pub-id-type="pmid">28530042</pub-id></mixed-citation>
              </ref>
              <ref id="R6">
                <label>6</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Idele</surname><given-names>P</given-names></string-name>, <string-name><surname>Gillespie</surname><given-names>A</given-names></string-name>, <string-name><surname>Porth</surname><given-names>T</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Epidemiology of HIV and AIDS among adolescents</article-title>. <source>J Acquir Immune Defic Syndr</source><year>2014</year>;<volume>66</volume>:<fpage>S144</fpage>–<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1097/QAI.0000000000000176</pub-id><pub-id pub-id-type="pmid">24918590</pub-id></mixed-citation>
              </ref>
              <ref id="R7">
                <label>7</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Koech</surname><given-names>E</given-names></string-name>, <string-name><surname>Teasdale</surname><given-names>CA</given-names></string-name>, <string-name><surname>Wang</surname><given-names>C</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Characteristics and outcomes of HIV-infected youth and young adolescents enrolled in HIV care in Kenya</article-title>. <source>AIDS</source><year>2014</year>;<volume>28</volume>:<elocation-id>2729-38</elocation-id>. <pub-id pub-id-type="doi">10.1097/QAD.0000000000000473</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/25493599?><pub-id pub-id-type="pmid">25493599</pub-id></mixed-citation>
              </ref>
              <ref id="R8">
                <label>8</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Grimsrud</surname><given-names>A</given-names></string-name>, <string-name><surname>Lesosky</surname><given-names>M</given-names></string-name>, <string-name><surname>Kalombo</surname><given-names>C</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Implementation and operational research</article-title>. <source>J Acquir Immune Defic Syndr</source><year>2016</year>;<volume>71</volume>:<fpage>e16</fpage>–<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1097/QAI.0000000000000863</pub-id><pub-id pub-id-type="pmid">26473798</pub-id></mixed-citation>
              </ref>
              <ref id="R9">
                <label>9</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cohen</surname><given-names>MS</given-names></string-name>, <string-name><surname>Chen</surname><given-names>YQ</given-names></string-name>, <string-name><surname>McCauley</surname><given-names>M</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Prevention of HIV-1 infection with early antiretroviral therapy</article-title>. <source>N Engl J Med</source><year>2011</year>;<volume>365</volume>:<fpage>493</fpage>–<lpage>505</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1105243</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/21767103?><pub-id pub-id-type="pmid">21767103</pub-id></mixed-citation>
              </ref>
              <ref id="R10">
                <label>10</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Flynn</surname><given-names>PM</given-names></string-name>, <string-name><surname>Rudy</surname><given-names>BJ</given-names></string-name>, <string-name><surname>Lindsey</surname><given-names>JC</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Long-Term observation of adolescents initiating HAART therapy: three-year follow-up</article-title>. <source>AIDS Res Hum Retroviruses</source><year>2007</year>;<volume>23</volume>:<elocation-id>1208-14</elocation-id>. <pub-id pub-id-type="doi">10.1089/aid.2006.0290</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/17961106?><pub-id pub-id-type="pmid">17961106</pub-id></mixed-citation>
              </ref>
              <ref id="R11">
                <label>11</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ferrand</surname><given-names>RA</given-names></string-name>, <string-name><surname>Briggs</surname><given-names>D</given-names></string-name>, <string-name><surname>Ferguson</surname><given-names>J</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Viral suppression in adolescents on antiretroviral treatment: review of the literature and critical appraisal of methodological challenges</article-title>. <source>Trop Med Int Health</source><year>2016</year>;<volume>21</volume>:<fpage>325-33</fpage>. <pub-id pub-id-type="doi">10.1111/tmi.12656</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/26681359?><pub-id pub-id-type="pmid">26681359</pub-id></mixed-citation>
              </ref>
              <ref id="R12">
                <label>12</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Marcus</surname><given-names>R</given-names></string-name>, <string-name><surname>Ferrand</surname><given-names>RA</given-names></string-name>, <string-name><surname>Kranzer</surname><given-names>K</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>The case for viral load testing in adolescents in resource-limited settings</article-title>. <source>J Int AIDS Soc</source><year>2017</year>;<volume>20 Suppl 7</volume>. <pub-id pub-id-type="doi">10.1002/jia2.25002</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/29171180?></mixed-citation>
              </ref>
              <ref id="R13">
                <label>13</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Petersen</surname><given-names>M</given-names></string-name>, <string-name><surname>Balzer</surname><given-names>L</given-names></string-name>, <string-name><surname>Kwarsiima</surname><given-names>D</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Association of implementation of a universal testing and treatment intervention with HIV diagnosis, receipt of antiretroviral therapy, and viral suppression in East Africa</article-title>. <source>JAMA</source><year>2017</year>;<volume>317</volume>:<fpage>2196-2206</fpage>. <pub-id pub-id-type="doi">10.1001/jama.2017.5705</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/28586888?><pub-id pub-id-type="pmid">28586888</pub-id></mixed-citation>
              </ref>
              <ref id="R14">
                <label>14</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Muri</surname><given-names>L</given-names></string-name>, <string-name><surname>Gamell</surname><given-names>A</given-names></string-name>, <string-name><surname>Ntamatungiro</surname><given-names>AJ</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Development of HIV drug resistance and therapeutic failure in children and adolescents in rural Tanzania: an emerging public health concern</article-title>. <source>AIDS</source><year>2017</year>;<volume>31</volume>:<elocation-id>61-70</elocation-id>. <pub-id pub-id-type="doi">10.1097/QAD.0000000000001273</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/27677163?><pub-id pub-id-type="pmid">27677163</pub-id></mixed-citation>
              </ref>
              <ref id="R15">
                <label>15</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Evans</surname><given-names>D</given-names></string-name>, <string-name><surname>Menezes</surname><given-names>C</given-names></string-name>, <string-name><surname>Mahomed</surname><given-names>K</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Treatment outcomes of HIV-infected adolescents attending public-sector HIV clinics across Gauteng and Mpumalanga, South Africa</article-title>. <source>AIDS Res Hum Retroviruses</source><year>2013</year>;<volume>29</volume>:<elocation-id>892-900</elocation-id>. <pub-id pub-id-type="doi">10.1089/AID.2012.0215</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/23373540?><pub-id pub-id-type="pmid">23373540</pub-id></mixed-citation>
              </ref>
              <ref id="R16">
                <label>16</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nglazi</surname><given-names>MD</given-names></string-name>, <string-name><surname>Kranzer</surname><given-names>K</given-names></string-name>, <string-name><surname>Holele</surname><given-names>P</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Treatment outcomes in HIV-infected adolescents attending a community-based antiretroviral therapy clinic in South Africa</article-title>. <source>BMC Infect Dis</source><year>2012</year>;<volume>12</volume>:<elocation-id>21</elocation-id>. <pub-id pub-id-type="doi">10.1186/1471-2334-12-21</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/22273267?><pub-id pub-id-type="pmid">22273267</pub-id></mixed-citation>
              </ref>
              <ref id="R17">
                <label>17</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Brown</surname><given-names>LB</given-names></string-name>, <string-name><surname>Ayieko</surname><given-names>J</given-names></string-name>, <string-name><surname>Mwangwa</surname><given-names>F</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Predictors of retention in HIV care among youth (15–24) in a universal Test-and-Treat setting in rural Kenya</article-title>. <source>J Acquir Immune Defic Syndr</source><year>2017</year>;<volume>76</volume>:<fpage>e15</fpage>–<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1097/QAI.0000000000001390</pub-id><pub-id pub-id-type="pmid">28394821</pub-id></mixed-citation>
              </ref>
              <ref id="R18">
                <label>18</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ford</surname><given-names>N</given-names></string-name>, <string-name><surname>Migone</surname><given-names>C</given-names></string-name>, <string-name><surname>Calmy</surname><given-names>A</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Benefits and risks of rapid initiation of antiretroviral therapy</article-title>. <source>AIDS</source><year>2018</year>;<volume>32</volume>:<elocation-id>17-23</elocation-id>. <pub-id pub-id-type="doi">10.1097/QAD.0000000000001671</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/29112073?><pub-id pub-id-type="pmid">29112073</pub-id></mixed-citation>
              </ref>
              <ref id="R19">
                <label>19</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Grimsrud</surname><given-names>A</given-names></string-name>, <string-name><surname>Bygrave</surname><given-names>H</given-names></string-name>, <string-name><surname>Doherty</surname><given-names>M</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Reimagining HIV service delivery: the role of differentiated care from prevention to suppression</article-title>. <source>J Int AIDS Soc</source><year>2016</year>;<volume>19</volume>:<elocation-id>21484</elocation-id>. <pub-id pub-id-type="doi">10.7448/IAS.19.1.21484</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/27914186?><pub-id pub-id-type="pmid">27914186</pub-id></mixed-citation>
              </ref>
              <ref id="R20">
                <label>20</label>
                <mixed-citation publication-type="book"><person-group person-group-type="author"><collab>NASCOP</collab></person-group>. <source>Differentiated care: operational guide</source>, <year>2017</year>.</mixed-citation>
              </ref>
              <ref id="R21">
                <label>21</label>
                <mixed-citation publication-type="book"><person-group person-group-type="author"><collab>National Institute for Health Care Excellence</collab></person-group>. <source>Depression in Adults: Recognition and Management: Clinical Guideline [CG90]</source>, <year>2009</year>.</mixed-citation>
              </ref>
              <ref id="R22">
                <label>22</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Richards</surname><given-names>DA</given-names></string-name></person-group>. <article-title>Stepped care: a method to deliver increased access to psychological therapies</article-title>. <source>Can J Psychiatry</source><year>2012</year>;<volume>57</volume>:<elocation-id>210-5</elocation-id>. <pub-id pub-id-type="doi">10.1177/070674371205700403</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/22480585?><pub-id pub-id-type="pmid">22480585</pub-id></mixed-citation>
              </ref>
              <ref id="R23">
                <label>23</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cornish</surname><given-names>PA</given-names></string-name>, <string-name><surname>Berry</surname><given-names>G</given-names></string-name>, <string-name><surname>Benton</surname><given-names>S</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Meeting the mental health needs of today's college student: reinventing services through stepped care 2.0</article-title>. <source>Psychol Serv</source><year>2017</year>;<volume>14</volume>:<elocation-id>428-442</elocation-id>. <pub-id pub-id-type="doi">10.1037/ser0000158</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/29120201?><pub-id pub-id-type="pmid">29120201</pub-id></mixed-citation>
              </ref>
              <ref id="R24">
                <label>24</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>van Straten</surname><given-names>A</given-names></string-name>, <string-name><surname>Hill</surname><given-names>J</given-names></string-name>, <string-name><surname>Richards</surname><given-names>DA</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Stepped care treatment delivery for depression: a systematic review and meta-analysis</article-title>. <source>Psychol Med</source><year>2015</year>;<volume>45</volume>:<elocation-id>231-46</elocation-id>. <pub-id pub-id-type="doi">10.1017/S0033291714000701</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/25065653?><pub-id pub-id-type="pmid">25065653</pub-id></mixed-citation>
              </ref>
              <ref id="R25">
                <label>25</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>van der Aa</surname><given-names>HPA</given-names></string-name>, <string-name><surname>van Rens</surname><given-names>GHMB</given-names></string-name>, <string-name><surname>Comijs</surname><given-names>HC</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Stepped care for depression and anxiety in visually impaired older adults: multicentre randomised controlled trial</article-title>. <source>BMJ</source><year>2015</year>;<volume>351</volume>:<elocation-id>h6127</elocation-id>. <pub-id pub-id-type="doi">10.1136/bmj.h6127</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/26597263?><pub-id pub-id-type="pmid">26597263</pub-id></mixed-citation>
              </ref>
              <ref id="R26">
                <label>26</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Smith</surname><given-names>DK</given-names></string-name>, <string-name><surname>Pals</surname><given-names>SL</given-names></string-name>, <string-name><surname>Herbst</surname><given-names>JH</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Development of a clinical screening index predictive of incident HIV infection among men who have sex with men in the United States</article-title>. <source>J Acquir Immune Defic Syndr</source><year>2012</year>;<volume>60</volume>:<elocation-id>421-7</elocation-id>. <pub-id pub-id-type="doi">10.1097/QAI.0b013e318256b2f6</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/22487585?><pub-id pub-id-type="pmid">22487585</pub-id></mixed-citation>
              </ref>
              <ref id="R27">
                <label>27</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kahle</surname><given-names>EM</given-names></string-name>, <string-name><surname>Hughes</surname><given-names>JP</given-names></string-name>, <string-name><surname>Lingappa</surname><given-names>JR</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>An empiric risk scoring tool for identifying high-risk heterosexual HIV-1-serodiscordant couples for targeted HIV-1 prevention</article-title>. <source>J Acquir Immune Defic Syndr</source><year>2013</year>;<volume>62</volume>:<elocation-id>339-47</elocation-id>. <pub-id pub-id-type="doi">10.1097/QAI.0b013e31827e622d</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/23187945?><pub-id pub-id-type="pmid">23187945</pub-id></mixed-citation>
              </ref>
              <ref id="R28">
                <label>28</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Balkus</surname><given-names>JE</given-names></string-name>, <string-name><surname>Brown</surname><given-names>E</given-names></string-name>, <string-name><surname>Palanee</surname><given-names>T</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>An empiric HIV risk scoring tool to predict HIV-1 acquisition in African women</article-title>. <source>J Acquir Immune Defic Syndr</source><year>2016</year>;<volume>72</volume>:<elocation-id>333-43</elocation-id>. <pub-id pub-id-type="doi">10.1097/QAI.0000000000000974</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/26918545?><pub-id pub-id-type="pmid">26918545</pub-id></mixed-citation>
              </ref>
              <ref id="R29">
                <label>29</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Menza</surname><given-names>TW</given-names></string-name>, <string-name><surname>Hughes</surname><given-names>JP</given-names></string-name>, <string-name><surname>Celum</surname><given-names>CL</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Prediction of HIV acquisition among men who have sex with men</article-title>. <source>Sex Transm Dis</source><year>2009</year>;<volume>36</volume>:<elocation-id>547-55</elocation-id>. <pub-id pub-id-type="doi">10.1097/OLQ.0b013e3181a9cc41</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/19707108?><pub-id pub-id-type="pmid">19707108</pub-id></mixed-citation>
              </ref>
              <ref id="R30">
                <label>30</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pintye</surname><given-names>J</given-names></string-name>, <string-name><surname>Drake</surname><given-names>AL</given-names></string-name>, <string-name><surname>Kinuthia</surname><given-names>J</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>A risk assessment tool for identifying pregnant and postpartum women who may benefit from preexposure prophylaxis</article-title>. <source>Clin Infect Dis</source><year>2017</year>;<volume>64</volume>:<fpage>751</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1093/cid/ciw850</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/28034882?><pub-id pub-id-type="pmid">28034882</pub-id></mixed-citation>
              </ref>
              <ref id="R31">
                <label>31</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Robbins</surname><given-names>GK</given-names></string-name>, <string-name><surname>Johnson</surname><given-names>KL</given-names></string-name>, <string-name><surname>Chang</surname><given-names>Y</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Predicting virologic failure in an HIV clinic</article-title>. <source>Clin Infect Dis</source><year>2010</year>:<fpage>100202083037053</fpage>–<lpage>000</lpage>. <pub-id pub-id-type="doi">10.1086/650537</pub-id></mixed-citation>
              </ref>
              <ref id="R32">
                <label>32</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Koller</surname><given-names>M</given-names></string-name>, <string-name><surname>Fatti</surname><given-names>G</given-names></string-name>, <string-name><surname>Chi</surname><given-names>BH</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Implementation and operational research</article-title>. <source>J Acquir Immune Defic Syndr</source><year>2015</year>;<volume>70</volume>:<fpage>e110</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1097/QAI.0000000000000748</pub-id><pub-id pub-id-type="pmid">26470034</pub-id></mixed-citation>
              </ref>
              <ref id="R33">
                <label>33</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>May</surname><given-names>M</given-names></string-name>, <string-name><surname>Sterne</surname><given-names>JAC</given-names></string-name>, <string-name><surname>Sabin</surname><given-names>C</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies</article-title>. <source>AIDS</source><year>2007</year>;<volume>21</volume>:<elocation-id>1185-97</elocation-id>. <pub-id pub-id-type="doi">10.1097/QAD.0b013e328133f285</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/17502729?><pub-id pub-id-type="pmid">17502729</pub-id></mixed-citation>
              </ref>
              <ref id="R34">
                <label>34</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Andersen</surname><given-names>RM</given-names></string-name></person-group>. <article-title>Revisiting the behavioral model and access to medical care: does it matter?</article-title><source>J Health Soc Behav</source><year>1995</year>;<volume>36</volume>:<elocation-id>1-10</elocation-id>.<?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/7738325?><pub-id pub-id-type="pmid">7738325</pub-id></mixed-citation>
              </ref>
              <ref id="R35">
                <label>35</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pantin</surname><given-names>H</given-names></string-name>, <string-name><surname>Schwartz</surname><given-names>SJ</given-names></string-name>, <string-name><surname>Sullivan</surname><given-names>S</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Ecodevelopmental HIV prevention programs for Hispanic adolescents</article-title>. <source>Am J Orthopsychiatry</source><year>2004</year>;<volume>74</volume>:<elocation-id>545-58</elocation-id>. <pub-id pub-id-type="doi">10.1037/0002-9432.74.4.545</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/15554814?><pub-id pub-id-type="pmid">15554814</pub-id></mixed-citation>
              </ref>
              <ref id="R36">
                <label>36</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Abrams</surname><given-names>DB</given-names></string-name></person-group>. <article-title>Treatment issues: towards a stepped-care model</article-title>. <source>Tob Control</source><year>1993</year>;<volume>2</volume>:<fpage>S17.2</fpage>–<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1136/tc.2.suppl1.S18</pub-id></mixed-citation>
              </ref>
              <ref id="R37">
                <label>37</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Glasgow</surname><given-names>RE</given-names></string-name>, <string-name><surname>Vogt</surname><given-names>TM</given-names></string-name>, <string-name><surname>Boles</surname><given-names>SM</given-names></string-name></person-group>. <article-title>Evaluating the public health impact of health promotion interventions: the RE-AIM framework</article-title>. <source>Am J Public Health</source><year>1999</year>;<volume>89</volume>:<fpage>1322</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.2105/ajph.89.9.1322</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/10474547?><pub-id pub-id-type="pmid">10474547</pub-id></mixed-citation>
              </ref>
              <ref id="R38">
                <label>38</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Weiner</surname><given-names>BJ</given-names></string-name>, <string-name><surname>Lewis</surname><given-names>CC</given-names></string-name>, <string-name><surname>Stanick</surname><given-names>C</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Psychometric assessment of three newly developed implementation outcome measures</article-title>. <source>Implement Sci</source><year>2017</year>;<volume>12</volume>:<fpage>108</fpage>. <pub-id pub-id-type="doi">10.1186/s13012-017-0635-3</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/28851459?><pub-id pub-id-type="pmid">28851459</pub-id></mixed-citation>
              </ref>
              <ref id="R39">
                <label>39</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Means</surname><given-names>AR</given-names></string-name>, <string-name><surname>Orlan</surname><given-names>E</given-names></string-name>, <string-name><surname>Gwayi-Chore</surname><given-names>M-C</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Structural readiness to implement community-wide mass drug administration programs for soil-transmitted helminth elimination: results from a three-country hybrid study</article-title>. <source>Implement Sci Commun</source><year>2021</year>;<volume>2</volume>:<fpage>80</fpage>. <pub-id pub-id-type="doi">10.1186/s43058-021-00164-3</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/34281614?><pub-id pub-id-type="pmid">34281614</pub-id></mixed-citation>
              </ref>
              <ref id="R40">
                <label>40</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>WHO ASSIST Working Group</collab></person-group>. <article-title>The alcohol, smoking and substance involvement screening test (assist): development, reliability and feasibility</article-title>. <source>Addiction</source><year>2002</year>;<volume>97</volume>:<fpage>1183</fpage>–<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1046/j.1360-0443.2002.00185.x</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/12199834?><pub-id pub-id-type="pmid">12199834</pub-id></mixed-citation>
              </ref>
              <ref id="R41">
                <label>41</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wright</surname><given-names>K</given-names></string-name>, <string-name><surname>Naar-King</surname><given-names>S</given-names></string-name>, <string-name><surname>Lam</surname><given-names>P</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Stigma scale revised: reliability and validity of a brief measure of stigma for HIV+ youth</article-title>. <source>J Adolesc Health</source><year>2007</year>;<volume>40</volume>:<fpage>96-8</fpage>. <pub-id pub-id-type="doi">10.1016/j.jadohealth.2006.08.001</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/17185215?><pub-id pub-id-type="pmid">17185215</pub-id></mixed-citation>
              </ref>
              <ref id="R42">
                <label>42</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>García-Moreno</surname><given-names>C</given-names></string-name>, <string-name><surname>Jansen</surname><given-names>H</given-names></string-name>, <string-name><surname>Ellsberg</surname><given-names>M</given-names></string-name></person-group>. <source>Book WHO multi-country study on women’s health and domestic violence against women</source>. <volume>204</volume>, <year>2005</year>.</mixed-citation>
              </ref>
              <ref id="R43">
                <label>43</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zimet</surname><given-names>GD</given-names></string-name>, <string-name><surname>Powell</surname><given-names>SS</given-names></string-name>, <string-name><surname>Farley</surname><given-names>GK</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Psychometric characteristics of the multidimensional scale of perceived social support</article-title>. <source>J Pers Assess</source><year>1990</year>;<volume>55</volume>:<elocation-id>610-7</elocation-id>. <pub-id pub-id-type="doi">10.1080/00223891.1990.9674095</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/2280326?><pub-id pub-id-type="pmid">2280326</pub-id></mixed-citation>
              </ref>
              <ref id="R44">
                <label>44</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kroenke</surname><given-names>K</given-names></string-name>, <string-name><surname>Spitzer</surname><given-names>RL</given-names></string-name>, <string-name><surname>Williams</surname><given-names>JB</given-names></string-name></person-group>. <article-title>The PHQ-9: validity of a brief depression severity measure</article-title>. <source>J Gen Intern Med</source><year>2001</year>;<volume>16</volume>:<fpage>606</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1046/j.1525-1497.2001.016009606.x</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/11556941?><pub-id pub-id-type="pmid">11556941</pub-id></mixed-citation>
              </ref>
              <ref id="R45">
                <label>45</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Spitzer</surname><given-names>RL</given-names></string-name>, <string-name><surname>Kroenke</surname><given-names>K</given-names></string-name>, <string-name><surname>Williams</surname><given-names>JBW</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>A brief measure for assessing generalized anxiety disorder: the GAD-7</article-title>. <source>Arch Intern Med</source><year>2006</year>;<volume>166</volume>:<elocation-id>1092</elocation-id>. <pub-id pub-id-type="doi">10.1001/archinte.166.10.1092</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/16717171?><pub-id pub-id-type="pmid">16717171</pub-id></mixed-citation>
              </ref>
              <ref id="R46">
                <label>46</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vaishnavi</surname><given-names>S</given-names></string-name>, <string-name><surname>Connor</surname><given-names>K</given-names></string-name>, <string-name><surname>Davidson</surname><given-names>JRT</given-names></string-name></person-group>. <article-title>An abbreviated version of the Connor-Davidson resilience scale (CD-RISC), the CD-RISC2: psychometric properties and applications in psychopharmacological trials</article-title>. <source>Psychiatry Res</source><year>2007</year>;<volume>152</volume>:<elocation-id>293-7</elocation-id>. <pub-id pub-id-type="doi">10.1016/j.psychres.2007.01.006</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/17459488?><pub-id pub-id-type="pmid">17459488</pub-id></mixed-citation>
              </ref>
              <ref id="R47">
                <label>47</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rohrbach</surname><given-names>LA</given-names></string-name>, <string-name><surname>Graham</surname><given-names>JW</given-names></string-name>, <string-name><surname>Hansen</surname><given-names>WB</given-names></string-name></person-group>. <article-title>Diffusion of a school-based substance abuse prevention program: predictors of program implementation</article-title>. <source>Prev Med</source><year>1993</year>;<volume>22</volume>:<elocation-id>237-60</elocation-id>. <pub-id pub-id-type="doi">10.1006/pmed.1993.1020</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/8483862?><pub-id pub-id-type="pmid">8483862</pub-id></mixed-citation>
              </ref>
              <ref id="R48">
                <label>48</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Johnson</surname><given-names>MO</given-names></string-name>, <string-name><surname>Neilands</surname><given-names>TB</given-names></string-name>, <string-name><surname>Dilworth</surname><given-names>SE</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>The role of self-efficacy in HIV treatment adherence: validation of the HIV treatment adherence self-efficacy scale (HIV-ASES)</article-title>. <source>J Behav Med</source><year>2007</year>;<volume>30</volume>:<fpage>359</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1007/s10865-007-9118-3</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/17588200?><pub-id pub-id-type="pmid">17588200</pub-id></mixed-citation>
              </ref>
              <ref id="R49">
                <label>49</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Damschroder</surname><given-names>LJ</given-names></string-name>, <string-name><surname>Aron</surname><given-names>DC</given-names></string-name>, <string-name><surname>Keith</surname><given-names>RE</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science</article-title>. <source>Implement Sci</source><year>2009</year>;<volume>4</volume>:<fpage>50</fpage>. <pub-id pub-id-type="doi">10.1186/1748-5908-4-50</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/19664226?><pub-id pub-id-type="pmid">19664226</pub-id></mixed-citation>
              </ref>
              <ref id="R50">
                <label>50</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Means</surname><given-names>AR</given-names></string-name>, <string-name><surname>Kemp</surname><given-names>CG</given-names></string-name>, <string-name><surname>Gwayi-Chore</surname><given-names>M-C</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Evaluating and optimizing the consolidated framework for implementation research (CFIR) for use in low- and middle-income countries: a systematic review</article-title>. <source>Implement Sci</source><year>2020</year>;<volume>15</volume>:<fpage>17</fpage>. <pub-id pub-id-type="doi">10.1186/s13012-020-0977-0</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/32164692?><pub-id pub-id-type="pmid">32164692</pub-id></mixed-citation>
              </ref>
              <ref id="R51">
                <label>51</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wiltsey Stirman</surname><given-names>S</given-names></string-name>, <string-name><surname>Baumann</surname><given-names>AA</given-names></string-name>, <string-name><surname>Miller</surname><given-names>CJ</given-names></string-name></person-group>. <article-title>The frame: an expanded framework for reporting adaptations and modifications to evidence-based interventions</article-title>. <source>Implement Sci</source><year>2019</year>;<volume>14</volume>:<fpage>58</fpage>. <pub-id pub-id-type="doi">10.1186/s13012-019-0898-y</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/31171014?><pub-id pub-id-type="pmid">31171014</pub-id></mixed-citation>
              </ref>
              <ref id="R52">
                <label>52</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Braun</surname><given-names>V</given-names></string-name>, <string-name><surname>Clarke</surname><given-names>V</given-names></string-name></person-group>. <article-title>Using thematic analysis in psychology</article-title>. <source>Qual Res Psychol</source><year>2006</year>;<volume>3</volume>:<fpage>77</fpage>–<lpage>101</lpage>. <pub-id pub-id-type="doi">10.1191/1478088706qp063oa</pub-id></mixed-citation>
              </ref>
              <ref id="R53">
                <label>53</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hsieh</surname><given-names>H-F</given-names></string-name>, <string-name><surname>Shannon</surname><given-names>SE</given-names></string-name></person-group>. <article-title>Three approaches to qualitative content analysis</article-title>. <source>Qual Health Res</source><year>2005</year>;<volume>15</volume>:<elocation-id>1277-88</elocation-id>. <pub-id pub-id-type="doi">10.1177/1049732305276687</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/16204405?><pub-id pub-id-type="pmid">16204405</pub-id></mixed-citation>
              </ref>
              <ref id="R54">
                <label>54</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tucker</surname><given-names>JD</given-names></string-name>, <string-name><surname>Iwelunmor</surname><given-names>J</given-names></string-name>, <string-name><surname>Abrams</surname><given-names>E</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Accelerating adolescent HIV research in low-income and middle-income countries: evidence from a research Consortium</article-title>. <source>AIDS</source><year>2021</year>;<volume>35</volume>:<fpage>2503</fpage>–<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1097/QAD.0000000000003049</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/34870930?><pub-id pub-id-type="pmid">34870930</pub-id></mixed-citation>
              </ref>
              <ref id="R55">
                <label>55</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nasuuna</surname><given-names>E</given-names></string-name>, <string-name><surname>Kigozi</surname><given-names>J</given-names></string-name>, <string-name><surname>Babirye</surname><given-names>L</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Low HIV viral suppression rates following the intensive adherence counseling (IAC) program for children and adolescents with viral failure in public health facilities in Uganda</article-title>. <source>BMC Public Health</source><year>2018</year>;<volume>18</volume>:<elocation-id>1048</elocation-id>. <pub-id pub-id-type="doi">10.1186/s12889-018-5964-x</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/30134880?><pub-id pub-id-type="pmid">30134880</pub-id></mixed-citation>
              </ref>
              <ref id="R56">
                <label>56</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Okonji</surname><given-names>EF</given-names></string-name>, <string-name><surname>Mukumbang</surname><given-names>FC</given-names></string-name>, <string-name><surname>Orth</surname><given-names>Z</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Psychosocial support interventions for improved adherence and retention in ART care for young people living with HIV (10-24 years): a scoping review</article-title>. <source>BMC Public Health</source><year>2020</year>;<volume>20</volume>:<elocation-id>1841</elocation-id>. <pub-id pub-id-type="doi">10.1186/s12889-020-09717-y</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/33261566?><pub-id pub-id-type="pmid">33261566</pub-id></mixed-citation>
              </ref>
              <ref id="R57">
                <label>57</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ekwunife</surname><given-names>OI</given-names></string-name>, <string-name><surname>Anetoh</surname><given-names>MU</given-names></string-name>, <string-name><surname>Kalu</surname><given-names>SO</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Conditional economic incentives and motivational interviewing to improve adolescents' retention in HIV care and adherence to antiretroviral therapy in Southeast Nigeria: study protocol for a cluster randomised trial</article-title>. <source>Trials</source><year>2018</year>;<volume>19</volume>:<elocation-id>710</elocation-id>. <pub-id pub-id-type="doi">10.1186/s13063-018-3095-4</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/30594223?><pub-id pub-id-type="pmid">30594223</pub-id></mixed-citation>
              </ref>
              <ref id="R58">
                <label>58</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Simms</surname><given-names>V</given-names></string-name>, <string-name><surname>Weiss</surname><given-names>HA</given-names></string-name>, <string-name><surname>Chinoda</surname><given-names>S</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Peer-led counselling with problem discussion therapy for adolescents living with HIV in Zimbabwe: a cluster-randomised trial</article-title>. <source>PLoS Med</source><year>2022</year>;<volume>19</volume>:<elocation-id>e1003887</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pmed.1003887</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/34986170?><pub-id pub-id-type="pmid">34986170</pub-id></mixed-citation>
              </ref>
              <ref id="R59">
                <label>59</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Willis</surname><given-names>N</given-names></string-name>, <string-name><surname>Milanzi</surname><given-names>A</given-names></string-name>, <string-name><surname>Mawodzeke</surname><given-names>M</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Effectiveness of community adolescent treatment supporters (cats) interventions in improving linkage and retention in care, adherence to art and psychosocial well-being: a randomised trial among adolescents living with HIV in rural Zimbabwe</article-title>. <source>BMC Public Health</source><year>2019</year>;<volume>19</volume>:<elocation-id>117</elocation-id>. <pub-id pub-id-type="doi">10.1186/s12889-019-6447-4</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/30691425?><pub-id pub-id-type="pmid">30691425</pub-id></mixed-citation>
              </ref>
              <ref id="R60">
                <label>60</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Enane</surname><given-names>LA</given-names></string-name>, <string-name><surname>Apondi</surname><given-names>E</given-names></string-name>, <string-name><surname>Omollo</surname><given-names>M</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>"I just keep quiet about it and act as if everything is alright" - The cascade from trauma to disengagement among adolescents living with HIV in western Kenya</article-title>. <source>J Int AIDS Soc</source><year>2021</year>;<volume>24</volume>:<elocation-id>e25695</elocation-id>. <pub-id pub-id-type="doi">10.1002/jia2.25695</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/33838007?><pub-id pub-id-type="pmid">33838007</pub-id></mixed-citation>
              </ref>
              <ref id="R61">
                <label>61</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mugo</surname><given-names>C</given-names></string-name>, <string-name><surname>Wilson</surname><given-names>KS</given-names></string-name>, <string-name><surname>Onyango</surname><given-names>A</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Brief report: time to repeat viral load testing among Unsuppressed adolescents and young adults living with HIV in Kenya</article-title>. <source>J Acquir Immune Defic Syndr</source><year>2020</year>;<volume>85</volume>:<fpage>606</fpage>–<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1097/QAI.0000000000002498</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/32897936?><pub-id pub-id-type="pmid">32897936</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
